Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

Arwa Z. Al-Riyami, Monika Hudoba, Sean Young, Donna Forrest*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)1788-1790
Number of pages3
JournalLeukemia and Lymphoma
Issue number8
Publication statusPublished - Aug 2013
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this